Monday, December 19, 2016

BRIEF-GSK announces start of phase III trails for asthma therapy

* GSK starts phase III study of once-daily closed triple

combination therapy FF/UMEC/VI in patients with asthma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)